{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:33:46Z","timestamp":1793424826956,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-022-04168-z","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T17:40:31Z","timestamp":1664991631000},"page":"2755-2763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES\u2013UTUC registry"],"prefix":"10.1007","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct02281188","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joyce","family":"Baard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Saita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliya","family":"Saltirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Revilla","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orcun","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"de la Rosette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"issue":"10092","key":"4168_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0140-6736(16)31592-6","volume":"390","author":"B Djulbegovic","year":"2017","unstructured":"Djulbegovic B, Guyatt GH (2017) Progress in evidence-based medicine: a quarter century on. Lancet 390(10092):415\u2013423. https:\/\/doi.org\/10.1016\/S0140-6736(16)31592-6","journal-title":"Lancet"},{"key":"4168_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","volume":"342","author":"JM Grimshaw","year":"1993","unstructured":"Grimshaw JM, Russel IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317\u20131322","journal-title":"Lancet"},{"issue":"7650","key":"4168_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-coello P et al (2008) GRADE\u202f: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","journal-title":"BMJ"},{"key":"4168_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/0391560320917805","author":"T Cai","year":"2020","unstructured":"Cai T, Cocci A, Gacci M, Verze P, Bonkat G, Koves B et al (2020) Guidelines in urology: lights and shadows. Urol J. https:\/\/doi.org\/10.1177\/0391560320917805","journal-title":"Urol J"},{"issue":"2","key":"4168_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2017.02.008","volume":"72","author":"SJ MacLennan","year":"2017","unstructured":"MacLennan SJ, MacLennan S, Bex A, Catto JWF, De Santis M, Glaser AW et al (2017) Changing current practice in urology: improving guideline development and implementation through stakeholder engagement. Eur Urol 72(2):161\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2017.02.008","journal-title":"Eur Urol"},{"issue":"18","key":"4168_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):839\u2013842","journal-title":"CMAJ"},{"issue":"1","key":"4168_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2020","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2020) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79(1):62\u201379","journal-title":"Eur Urol"},{"issue":"1","key":"4168_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0170365","volume":"12","author":"S Pavan","year":"2017","unstructured":"Pavan S, Rommel K, Marquina MEM, H\u00f6hn S, Lanneau V, Rath A (2017) Clinical practice guidelines for rare diseases: the orphanet database. PLoS ONE 12(1):1\u201314","journal-title":"PLoS ONE"},{"key":"4168_CR9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC et al (1999) Why don t physicians follow a framework for improvement. JAMA 282:1458\u20131465","journal-title":"JAMA"},{"issue":"7","key":"4168_CR10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1515\/cclm-2015-0871","volume":"54","author":"JH Barth","year":"2016","unstructured":"Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, Twomey PJ et al (2016) Why are clinical practice guidelines not followed? The European Federation of Clinical Chemistry and Laboratory Medicine and European Union of Medical Specialists joint working group on Guidelines. Clin Chem Lab Med 54(7):1133\u20131139","journal-title":"Clin Chem Lab Med"},{"key":"4168_CR11","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester R, Burger M et al (2014) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Limited update April 2014. http:\/\/uroweb.org"},{"issue":"5","key":"4168_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupr\u00eat","year":"2015","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester RJ, Burger M et al (2015) European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68(5):868\u2013879","journal-title":"Eur Urol"},{"key":"4168_CR13","unstructured":"Roupret M, Babjuk M, B\u00f6hle M, Burger E, Comp\u00e9rat N, Cowan E et al (2016) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma. http:\/\/uroweb.org"},{"issue":"1","key":"4168_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Comp\u00e9rat E, Cowan N, Gontero P et al (2018) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"key":"4168_CR15","doi-asserted-by":"crossref","unstructured":"Roupret M, Babjuk M, Burger M, Comp\u00e9rat E, Cowan NC, Gontero P et al (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma. http:\/\/uroweb.org","DOI":"10.1016\/j.eururo.2017.07.036"},{"key":"4168_CR16","doi-asserted-by":"crossref","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Comp\u00e9rat E, Cowan NC, Gontero P et al (2019) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma. http:\/\/uroweb.org","DOI":"10.1016\/j.eururo.2017.07.036"},{"issue":"1","key":"4168_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/15363","volume":"9","author":"J Baard","year":"2020","unstructured":"Baard J, Celebi M, de la Rosette J, Alcaraz A, Shariat S, Cormio L et al (2020) Evaluation of patterns of presentation, practice, and outcomes of upper tract urothelial cancer: Protocol for an observational, international, multicenter, cohort study by the clinical research office of the endourology society. JMIR Res Protoc 9(1):1\u201310","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"4168_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2021) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79(1):62\u201379","journal-title":"Eur Urol"},{"key":"4168_CR19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","volume":"108","author":"J Messer","year":"2011","unstructured":"Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS et al (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU 108:701\u2013705","journal-title":"BJU"},{"key":"4168_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.urology.2016.04.030","volume":"96","author":"AM Potretzke","year":"2016","unstructured":"Potretzke AM, Knight BA, Vetter JM, Anderson BG, Hardi AC, Bhayani SB et al (2016) Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature. Urology 96:35\u201343. https:\/\/doi.org\/10.1016\/j.urology.2016.04.030","journal-title":"Urology"},{"issue":"12","key":"4168_CR21","first-page":"1","volume":"56","author":"P Martingano","year":"2020","unstructured":"Martingano P, Cavallaro MFM, Bozzato AM, Baratella E, Cova MA (2020) Ct urography findings of upper urinary tract carcinoma and its mimickers: a pictorial review. Medicina (B Aires) 56(12):1\u201315","journal-title":"Medicina (B Aires)"},{"issue":"8","key":"4168_CR22","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.urolonc.2012.05.010","volume":"31","author":"CP Rojas","year":"2013","unstructured":"Rojas CP, Castle SM, Llanos CA, Cortes JAS, Bird V, Rodriguez S et al (2013) Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. Urol Oncol Semin Orig Investig 31(8):1696\u20131700. https:\/\/doi.org\/10.1016\/j.urolonc.2012.05.010","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"9","key":"4168_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/end.2020.0246","volume":"34","author":"JE Freund","year":"2020","unstructured":"Freund JE, Duivenvoorden MJC, Sikma BT, Vernooij RWM, Savci-Heijink CD, Legemate JD et al (2020) The diagnostic yield and concordance of ureterorenoscopic biopsies for grading of upper tract urothelial carcinoma: a Dutch nationwide analysis. J Endourol 34(9):907\u2013913","journal-title":"J Endourol"},{"issue":"11","key":"4168_CR24","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.ejso.2020.06.024","volume":"46","author":"JD Subiela","year":"2020","unstructured":"Subiela JD, Territo A, Mercad\u00e9 A, Bala\u00f1\u00e0 J, Aumatell J, Calderon J et al (2020) Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis. Eur J Surg Oncol 46(11):1989\u20131997","journal-title":"Eur J Surg Oncol"},{"key":"4168_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.euf.2021.03.018","volume":"8","author":"G Marcq","year":"2021","unstructured":"Marcq G, Foerster B, Abufaraj M, Matin SF, Azizi M, Gupta M et al (2021) Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney-sparing strategies: an international collaborative study. Eur Urol Focus 8:491\u2013497","journal-title":"Eur Urol Focus"},{"issue":"1","key":"4168_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","volume":"109","author":"RL Favaretto","year":"2012","unstructured":"Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109(1):77\u201382","journal-title":"BJU Int"},{"key":"4168_CR27","first-page":"4","volume":"8","author":"S Katayama","year":"2021","unstructured":"Katayama S, Mori K, Schuettfort VM, Pradere B, Mostafaei H, Quhal F et al (2021) Accuracy and clinical utility of a tumor grade- and stage-based predictive model in localized upper tract urothelial carcinoma. Eur Urol Focus 8:4\u201311","journal-title":"Eur Urol Focus"},{"issue":"4","key":"4168_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.eururo.2021.05.004","volume":"80","author":"B Foerster","year":"2021","unstructured":"Foerster B, Abufaraj M, Matin SF, Azizi M, Gupta M, Li WM et al (2021) Pretreatment risk stratification for endoscopic kidney-sparing surgery in upper tract urothelial carcinoma: an international collaborative study. Eur Urol 80(4):507\u2013515","journal-title":"Eur Urol"},{"key":"4168_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P, Leon P, Utard G, Mozer P et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67:1122\u20131133","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-04168-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T13:47:45Z","timestamp":1701179265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-04168-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["4168"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-04168-z","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Joyce Baard: None. Shahrokh F. Shariat: advisor for Urogen. Morgan Roupret: advisor for Urogen, Roche, Ipsen, Astellas, Astra Zeneca, Janssen. Takashi Yoshida: none. Alberto Saita: none. Iliya Saltirov: none. Javier Burgos Revilla: none. Orcun Celik: none. Jean de la Rosette: none. Pilar Laguna<b>:<\/b> none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study. Institutional review board approval was requested and was waived according to the Medical Research Involving Human Subjects Act (date of resolution: October 15, 2014; ref W14-273#14.17.329). Informed consent was not required, all information was anonymized and the submission does not include any images that may identify the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All the procedures being performed were part of the routine care and in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}